Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin-Reference-Cited by-同舟云学术

Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin

Published:2023-10 Issue:5 Volume:21 Page:e394-e404
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Jindal Tanya^ORCID,Zhang Li,Deshmukh Prianka,Reyes Kevin,Chan Emily,Kumar Vipul,Zhu Xiaolin,Maldonado Edward,Feng Stephanie,Johnson Michelle,Angelidakis Austin,Kwon Daniel,Desai Arpita,Borno Hala T.,Bose Rohit,Wong Anthony,Hong Julian,Carroll Peter,Meng Maxwell,Porten Sima,Aggarwal Rahul,Small Eric J.,Fong Lawrence,Chou Jonathan,Friedlander Terence,de Kouchkovsky Ivan,Koshkin Vadim S.^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference33 articles.

1. The 2016 WHO classification of tumours of the urinary system and male genital organs – Part B: prostate and bladder tumours;Humphrey;Eur Urol,2016

2. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry;Lopez-Beltran;J Clin Pathol,2007

3. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer;Matulay;Urol Oncol,2019

4. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology;Vetterlein;Cancer,2017

5. Genomic characterization of bladder cancer with variant histology;Lenis;J Clin Oncol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer;Journal of Clinical Oncology;2024-07-10

2. C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study;Cancers;2024-04-28

3. Antibody–Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data;Current Oncology;2024-04-19

4. One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract;Current Treatment Options in Oncology;2024-02